Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.
Related Posts
These 6 stocks rose as Nvidia fell into correction territory
Five of the six stocks have risen by an average of 6.75% alongside Nvidia’s fall from all-time highs.
Tesla set to report second-quarter earnings after the bell
Tesla’s second quarter earnings call comes as Elon Musk’s automaker tries to revitalize EV sales and turn its robotaxis into moneymakers.
How AI regulation could shake out in 2025
This year will be a year of change for the U.S. political landscape — and that comes with big implications for the direction of travel […]